Article Details

Novo Nordisk's high-dose Wegovy increases weight loss and remains safe

Retrieved on: 2025-01-21 00:19:18

Tags for this article:

Click the tags to see associated articles and topics

Novo Nordisk's high-dose Wegovy increases weight loss and remains safe. View article details on hiswai:

Excerpt

The gold standard of business intelligence. ... From a mean baseline body weight of 113kg, subjects who received high dose Wegovy experienced weight ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up